Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: Rate of onset and radius of diffusion

被引:61
作者
Flynn, TC
Clark, RE
机构
[1] Cary Skin Ctr, Cary, NC 27519 USA
[2] Univ N Carolina, Dept Dermatol, Chapel Hill, NC 27514 USA
关键词
D O I
10.1046/j.1524-4725.2003.29124.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUND. Botulinum toxin types A and B can improve the appearance of facial wrinkles. Differences in the time until onset and the degree of diffusion have been observed anecdotally, but no direct comparative studies have been done. OBJECTIVE. To compare the rate of onset and the radius of diffusion of botulinum toxin types A and B in the rhytides of the forehead. METHODS. Adults with symmetrical moderate to severe forehead wrinkles at full contracture received botulinum toxin type A (BOTOX; 5 U) on one side of the forehead and type B (MYOBLOC; 500 U) on the other side. Photographs taken at rest and full frontalis contracture were analyzed by computer, and a time-lapse motion picture was created. Radius of diffusion and time until full effect were measured. RESULTS. Botulinum toxin type B had a slightly faster onset of action than type A. All patients responded to type B quickly, whereas some had a delayed response to type A. A greater radius of diffusion was consistently observed with botulinum toxin type B, as measured by the greater area of wrinkle reduction at the doses used. CONCLUSIONS. In this comparative study of patients with symmetrical forehead wrinkles, botulinum toxin type B produced a greater area of diffusion and a more rapid onset of action than type A.
引用
收藏
页码:519 / 522
页数:4
相关论文
共 19 条
[1]   Botulinum toxin A for the treatment of facial hyperkinetic wrinkle lines in Koreans [J].
Ahn, KY ;
Park, MY ;
Park, DH ;
Han, DG .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2000, 105 (02) :778-784
[2]  
BAUMANN L, 2002, WORLD C DERM JUL
[3]   The cosmetic uses of Botulinum toxin type A [J].
Benedetto, AV .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1999, 38 (09) :641-655
[4]  
BLITZER A, 1993, ARCH OTOLARYNGOL, V119, P1018
[5]  
BLITZER A, MANAGEMENT HYPERFUNC
[6]   Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia [J].
Brashear, A ;
Lew, MF ;
Dykstra, DD ;
Comella, CL ;
Factor, SA ;
Rodnitzky, RL ;
Trosch, R ;
Singer, C ;
Brin, MF ;
Murray, JJ ;
Wallace, JD ;
Willmer-Hulme, A ;
Koller, M .
NEUROLOGY, 1999, 53 (07) :1439-1446
[7]   Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: Adjunctive use in facial aesthetic surgery [J].
Fagien, S .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1999, 103 (02) :701-713
[8]  
Goodman G, 1998, Australas J Dermatol, V39, P158, DOI 10.1111/j.1440-0960.1998.tb01272.x
[9]   Local injection into mimetic muscles of botulinum toxin A for the treatment of facial lines [J].
Guerrissi, J ;
Sarkissian, P .
ANNALS OF PLASTIC SURGERY, 1997, 39 (05) :447-453
[10]   LONGITUDINAL EXPERIENCE WITH BOTULINUM TOXIN INJECTIONS FOR TREATMENT OF BLEPHAROSPASM AND CERVICAL DYSTONIA [J].
JANKOVIC, J ;
SCHWARTZ, KS .
NEUROLOGY, 1993, 43 (04) :834-836